Practice Management
Practice Management
03/22/2016
The FDA has proposed a ban on powdered medical gloves, approved new requirements for opioid warning labels, and approved a new treatment for inhalational anthrax.
03/22/2016
Practice Management
Practice Management
03/22/2016
The FDA has proposed a ban on powdered medical gloves, approved new requirements for opioid warning labels, and approved a new treatment for inhalational anthrax.
03/22/2016
Vaccines
Vaccines
03/07/2016
The FDA’s Vaccines and Related Biological Advisory Committee has accepted recommendations from the World Health Organization on which flu vaccines to issue next season.
03/07/2016
Vaccines
Vaccines
03/07/2016
The FDA’s Vaccines and Related Biological Advisory Committee has accepted recommendations from the World Health Organization on which flu vaccines to issue next season.
03/07/2016
Vaccines
Vaccines
03/07/2016
The FDA’s Vaccines and Related Biological Advisory Committee has accepted recommendations from the World Health Organization on which flu vaccines to issue next season.
03/07/2016
FDA Alerts
FDA Alerts
02/05/2016
FDA Alerts
FDA Alerts
01/29/2016
The FDA has approved a new drug for the treatment of chronic hepatitis C virus genotypes 1 and 4 infection.
01/29/2016
FDA Alerts
FDA Alerts
01/29/2016
The FDA has approved a new drug for the treatment of chronic hepatitis C virus genotypes 1 and 4 infection.
01/29/2016
FDA Alerts
FDA Alerts
01/29/2016
The FDA has approved a new drug for the treatment of chronic hepatitis C virus genotypes 1 and 4 infection.
01/29/2016
Neurology
Neurology
01/22/2016
The FDA has approved new options for lower limb spasticity, relapsed multiple myeloma, and diabetic foot ulcers that healthcare professionals should be aware of.
01/22/2016